On 2026-08-04 15:44:38 (Saudi Time), Specialized Medical Company (SMC Healthcare) announced its Interim financial results for the six months ended on June 30, 2026.

Year-on-Year Performance Drivers

For the six-month period ending 30 June 2026, SMC Healthcare's revenue grew 4.516% YoY to SAR 782.00 million (SAR 782,002 thousand) from SAR 748.21 million (SAR 748,209 thousand), driven by increased outpatient clinic activity and the growing contribution from new clinics opened progressively during 2025 as they continued to ramp up operations, further supported by higher inpatient revenue stemming from the increased outpatient activity. Net profit attributable to shareholders rose 17.767% YoY to SAR 77.73 million (SAR 77,729 thousand) from SAR 66.00 million (SAR 66,002 thousand), with net profit growth exceeding revenue growth, underpinned by the expansion of the clinic network, improved operating efficiency, higher contribution from higher-margin inpatient services, disciplined operating expense management, and lower finance costs.

Quarter-on-Quarter Performance Drivers

QoQ revenue rose 5.425% to SAR 401.33 million (SAR 401,327 thousands / 1,000 = SAR 401.33 million), driven by a recovery in patient volumes following the Q1 seasonal drag from Ramadan, the Eid vacation, and the extended school break, as well as the continued ramp-up of new clinics opened during 2025 and a growing contribution from the higher-margin acute care mix. Net profit surged 38.798% QoQ to SAR 45.18 million (SAR 45,179 thousands / 1,000 = SAR 45.18 million), supported by the same volume recovery, improved operating cost efficiency, and an enhanced business mix that collectively drove stronger revenue and expanded profit margins.

Other Items

The external auditor issued an unmodified conclusion on SMC Healthcare's interim condensed consolidated financial results for the six months ended 30 June 2026, with no additional comments noted in any other matter, conservation, notice, disclaimer of opinion, or adverse opinion paragraphs. No material risks, going concern uncertainties, or debt covenant breaches were flagged. Total shareholders' equity (after deducting minority equity) stood at SAR 982,685 thousand as of the current period, compared to SAR 992,354 thousand in the same period of the prior year, representing a decline of 0.974%. Earnings per share for the current period were SAR 0.31, up from SAR 0.26 in the corresponding prior-year period. EBITDA for Q2 2026 reached SAR 82.8 million, with an EBITDA margin of 20.6%, compared with 19.6% in Q2 2025, as stated by the company in this announcement. The net profit margin for Q2 2026 expanded to 11.3%, compared with 9.6% in the corresponding period of the previous year, as noted by the company. Certain figures for the comparison period have been reclassified to conform to the presentation in the current period.

Original announcement:

Attached PDF document link:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.